INTRODUCTION {#SEC1}
============

*N* ^6^-methyladenosine (m^6^A) is the most abundant internal modification of messenger RNAs (mRNAs) and has known functions in RNA splicing, export, translation and decay ([@B1]). m^6^A is a reversible and dynamic modification that is introduced at a subset of RR[A]{.ul}CH motifs (R = A/G, H = A/C/U) through the activity of the m^6^A methyltransferase complex, composed of methyltransferase-like 3 (METTL3), METTL14 and Wilms tumor 1 associated protein ([@B2],[@B3]), and reversed by two m^6^A demethylases, fat mass and obesity associated protein and AlkB family member 5 (ALKBH5) ([@B4],[@B5]). Consistent with the dynamic character of m^6^A modifications, m^6^A sites span a wide range of modification fractions ([@B6]), and cellular conditions such as heat shock can lead to changes in m^6^A modification levels and patterns ([@B7],[@B8]). Dynamic m^6^A modifications add another dimension to the regulation of the life cycle of cellular RNAs.

m^6^A modifications impact the fate of modified RNAs by influencing their interactions with m^6^A 'reader' proteins. Proteins containing YT521-B homology (YTH) domains directly bind the *N*^6^-methyl group of m^6^A, resulting in the regulation of mRNA splicing, translation, and decay ([@B9]--[@B17]). m^6^A modifications also influence biological RNA structures, as shown both in biophysical studies *in vitro* ([@B18]) and in transcriptome-wide mapping studies *in vivo* ([@B19],[@B20]). m^6^A-induced changes in RNA structure can alter the accessibility of protein binding sites, thereby influencing protein binding. The m^6^A reader protein HNRNPC (heterogeneous nuclear ribonucleoprotein C) binds m^6^A-modified RNA through this 'm^6^A-switch' mechanism, in which the m^6^A-mediated destabilization of an RNA hairpin exposes a single-stranded HNRNPC binding motif ([@B20]). Given the impact of RNA structure on protein binding, m^6^A-switch-like changes in RNA structure likely have a widespread effect on the binding of many proteins to m^6^A-modified RNAs. In addition to HNRNPC, other m^6^A reader proteins lacking a YTH domain have been shown to regulate pri-miRNA processing and mRNA translation ([@B21],[@B22]). These reader proteins might recognize m^6^A-modified RNAs by directly binding the m^6^A base or through m^6^A-induced changes in RNA structure.

mRNAs interact with proteins throughout their life cycle. These interactions constitute a crucial and widespread mechanism for the regulation of mRNA transcription, processing, translation and stability. Interactome studies have expanded the number of RNA binding proteins identified in the human genome to ∼1,500 ([@B23],[@B24]). Many of the newly discovered RNA binding proteins do not possess canonical RNA binding domains. Furthermore, it has become increasingly clear that intrinsically disordered regions and low-complexity sequences have widespread roles in RNA binding ([@B24]). Low-complexity sequences are protein regions with an amino acid composition that is highly biased in such a way that they are unlikely to fold into a globular structure. Low-complexity sequences have been implicated in the formation of both normal and pathological ribonucleoprotein assemblies, including cellular granules as well as protein aggregates characteristic of neurodegenerative diseases ([@B25]--[@B27]). Moreover, RNA binding proteins with low-complexity regions frequently function as protein--protein interaction hubs and are therefore ideally positioned for the regulation of RNA--protein interactions and RNA metabolism ([@B24]). Among the m^6^A reader proteins identified so far, several have been shown to bind m^6^A-modified RNAs using globular YTH domains or RNA recognition motifs ([@B12]--[@B15],[@B20]). Although some of these m^6^A reader proteins contain low-complexity sequences, these regions have not been implicated in the binding of m^6^A-modified RNAs. Given their increasingly recognized roles in RNA biology, low-complexity regions likely contribute to the recognition of m^6^A-modified RNAs by some m^6^A readers.

Here, we report that heterogeneous nuclear ribonucleoprotein G (HNRNPG) is a new m^6^A reader protein that uses a low-complexity region to recognize a motif exposed by m^6^A modification. We first identified HNRNPG as a protein that preferentially binds to the m^6^A-modified form of a hairpin from the long noncoding RNA (lncRNA) metastasis associated lung adenocarcinoma transcript 1 (MALAT1). HNRNPG binds a purine-rich region that can overlap with the m^6^A consensus sequence and is exposed upon m^6^A modification. Moreover, HNRNPG binding is mediated by a low-complexity region rather than a canonical RNA binding domain. Transcriptome-wide studies further identified 13,191 high-confidence m^6^A sites bound by HNRNPG, while *HNRNPG* knockdown and m^6^A methyltransferase knockdown led to correlated changes in mRNA splicing. Thus, HNRNPG uses its low-complexity region to bind purine-rich sequences exposed upon m^6^A modification of RNA, and thereby functions in the regulation of gene expression and alternative splicing.

MATERIALS AND METHODS {#SEC2}
=====================

Mammalian cell culture, siRNA knockdown and cell fractionation {#SEC2-1}
--------------------------------------------------------------

Human cervical adenocarcinoma cell line HeLa (CCL-2) and human embryonic kidney (HEK) cell line HEK293T (CRL-11268) were obtained from the American Type Culture Collection (ATCC) and cultured under standard conditions. Control siRNA (1027281, Qiagen), METTL3 siRNA (SI04317096, Qiagen), METTL14 siRNA (SI00459942, Qiagen) or HNRNPG siRNA (SI00700084 and SI00700077, Qiagen) was transfected into HEK293T cells at a concentration of 20--50 nM, using Lipofectamine RNAiMAX (13778100, Invitrogen) according to the manufacturer\'s instructions. Cells were collected 48 h after transfection, shock-frozen in liquid nitrogen and stored at −80°C for further studies.

Nuclear and cytoplasmic extracts were isolated using the NE-PER Nuclear and Cytoplasmic Extraction Reagents (78833, Thermo Scientific) according to the manufacturer\'s instructions.

Western blotting {#SEC2-2}
----------------

Western blots were performed using standard procedures. Briefly, 10--30 μg protein samples were separated on 4--12% polyacrylamide Bis-Tris gels (NP0336BOX, Invitrogen) and transferred to polyvinylidene fluoride membranes (IPVH00010, Millipore). The blots were probed with METTL3- (15073-1-AP, Proteintech), METTL14- (HPA038002, Sigma), HNRNPG- (sc-14581 and sc-48796, Santa Cruz Biotechnology) or GAPDH- (A00192-40, Genscript) specific primary antibody, followed by rabbit anti-goat IgG-HRP (sc-2768, Santa Cruz Biotechnology) or goat anti-rabbit IgG-HRP (ab97051, Abcam) secondary antibody, and then visualized by enhanced chemoluminescence (RPN2109, GE Healthcare).

Protein expression {#SEC2-3}
------------------

For expression of the N-terminal RNA recognition motif (N-RRM, residues 1--83) and C-terminal RNA binding domain (C-RBD, residues 334--391) of human HNRNPG protein, sequences encoding these HNRNPG domains were amplified by polymerase chain reaction (PCR) from human HeLa cDNA libraries (637203, Clontech) and then subcloned into pGEX-6p-1 expression vectors using BamHI and XhoI restriction sites. Plasmid DNA was transformed into *Escherichia coli* BL21-CodonPlus(DE3)-RP or BL21-CodonPlus(DE3)-RIL cells (Agilent). The transformed bacteria were grown to saturation at 37°C, 200 rpm in Luria--Bertani Lennox medium with 100 μg/ml ampicillin, then diluted 1:100, grown in the same culture medium to an absorbance of ∼0.6 at 600 nm, and induced with 1 mM isopropyl β-D-1-thiogalactoside (IPTG). The bacteria were grown an additional 16--22 h at 18°C, 200 rpm, then harvested and sonicated at 4°C. GST-fusion proteins were isolated from the soluble lysate using glutathione-Sepharose beads and stored in 10 mM Tris-Cl (pH 7.4), 100 mM KCl, 2.5 mM MgCl~2~, 30% glycerol at −80°C.

RNA oligos {#SEC2-4}
----------

The following RNA oligos were synthesized by Q.D. and purified by high-performance liquid chromatography (HPLC) and/or denaturing gel electrophoresis, as previously described ([@B28]).

The RNA oligos used in Figures [1](#F1){ref-type="fig"}, [2C](#F2){ref-type="fig"}--[D](#F2){ref-type="fig"}, and [3C](#F3){ref-type="fig"} and [Supplementary Figure S2A](#sup1){ref-type="supplementary-material"}:

![HNRNPG preferentially binds an m^6^A-modified hairpin in MALAT1. (**A**) Secondary structure of the 34-nt hairpin derived from positions 2,505--2,538 of MALAT1, including the m^6^A site at position 2,515. The methylated form of the hairpin is termed 2,515-m^6^A and the unmethylated form is termed 2,515-A. (**B**) Gel shift showing binding of HeLa nuclear extract to the MALAT1 hairpin in both its unmethylated (2,515-A) and methylated (2,515-m^6^A) forms. (**C**) Left: denaturing gel of the proteins pulled down by the unmethylated and methylated MALAT1 hairpins. In the control, no RNA was used as bait. Right: quantification of relative HNRNPG pull-down with the unmethylated and methylated hairpins, normalized to pulled-down Histone H1.2 (HIST1H1C). Data shown as mean; error bar = standard deviation; *n* = 4 biological replicates.](gkx141fig1){#F1}

![HNRNPG uses a low-complexity region to bind the MALAT1 hairpin. (**A**) Domain structure of HNRNPG, including an N-terminal RNA recognition motif (RRM) and an SRGP-rich low-complexity region, which contains the nascent transcripts targeting domain (NTD) and a C-terminal RNA binding domain (RBD). (**B**) Electron microscopy images of the N-terminal RRM (N-RRM) and C-terminal RBD (C-RBD) of HNRNPG at 5 μM concentration. C-RBD aggregates are marked by arrows. (**C**) Gel shift showing the ribonucleoprotein (RNP) complexes that form upon binding of the C-RBD of HNRNPG (0--20 μM) to the unmethylated and methylated MALAT1 hairpins. The free RNA is not shown, as it has run much farther down the gel. Top: ^32^P-labeled RNA gel; bottom: same gel stained for protein. (**D**) Ultraviolet cross-linking of the HNRNPG C-RBD, C-RBD mutant and N-RRM (0--5 μM) to the unmethylated and methylated MALAT1 hairpins. In the C-RBD mutant, all three RGG repeats in the C-RBD were mutated to FGG repeats.](gkx141fig2){#F2}

![m^6^A alters RNA structure to recruit HNRNPG. (**A**) Sequence logo of the most enriched motif within HNRNPG PAR-CLIP peaks. (**B**) Left: secondary structure of the MALAT1 hairpin, showing the A-2,515-to-G/C/U mutations that were introduced at the m^6^A site. Right: quantification of relative HNRNPG pull-down with the original (2,515-A) and mutated (2,515-G/C/U) MALAT1 hairpins, normalized to pulled-down HIST1H1C. Data shown as mean; error bar = standard deviation; *n* = 3 biological replicates. (**C**) Left: structural probing of the unmethylated and methylated MALAT1 hairpins. The orange lines indicate regions with marked differences between the unmethylated and methylated hairpins. The location of the m^6^A residue is indicated by a red dot. Ctrl, no nuclease added; V1; RNase V1 digestion; S1, S1 nuclease digestion; T1, RNase T1 digestion; G-L, G-ladder; AH, alkaline hydrolysis. Right: secondary structure of the unmethylated and methylated MALAT1 hairpins, marked at their S1 nuclease (red lines) and V1 nuclease (green lines) cleavage sites. (**D**) Model showing that m^6^A disrupts RNA structure, exposes a motif that includes the m^6^A site, and recruits an RNA binding protein.](gkx141fig3){#F3}

2,515-A: 5΄- AAUGUGAAGG[A]{.ul}CUUUCGUAACGGAAGUAAUUCAA-Biotin;

2,515-m^6^A: 5΄- AAUGUGAAGG[m^6^A]{.ul}CUUUCGUAACGGAAGUAAUUCAA-Biotin.

The RNA oligos used in Figure [3B](#F3){ref-type="fig"}:

2,515-A: 5΄- AAUGUGAAGG[A]{.ul}CUUUCGUAACGGAAGUAAUUCAA-Biotin;

2,515-G: 5΄- AAUGUGAAGG[G]{.ul}CUUUCGUAACGGAAGUAAUUCAA-Biotin;

2,515-C: 5΄- AAUGUGAAGG[C]{.ul}CUUUCGUAACGGAAGUAAUUCAA-Biotin;

2,515-U: 5΄- AAUGUGAAGG[U]{.ul}CUUUCGUAACGGAAGUAAUUCAA-Biotin.

The RNA oligos used in [Supplementary Figure S2B](#sup1){ref-type="supplementary-material"}:

\#1: 5΄-AAUGUGA[U]{.ul}GG[m^6^A]{.ul}CUUUCGUAACGGAAGUAA[A]{.ul}UCAA-Biotin;

\#2: 5΄-AAUGUGAA[A]{.ul}G[m^6^A]{.ul}CUUUCGUAACGGAAGUA[G]{.ul}UUCAA-Biotin;

\#3: 5΄-AAUGUGAAG[Am^6^A]{.ul}CUUUCGUAACGGAAGU[G]{.ul}AUUCAA-Biotin;

\#4: 5΄-AAUGUGAAGG[U]{.ul}CUUUCGUAACGGAAG[m^6^A]{.ul}AAUUCAA-Biotin;

\#5: 5΄-AAUGUGAAGG[m^6^AG]{.ul}UUUCGUAACGGAA[C]{.ul}UAAUUCAA-Biotin.

The RNA oligos used in [Supplementary Figure S2C](#sup1){ref-type="supplementary-material"} were transcribed *in vitro* with T7 RNA polymerase and purified by denaturing gel electrophoresis:

2,518-U & 2,528-A:

5΄-GAAAAAUGUGAAGGACU[U]{.ul}UCGUAACGG[A]{.ul}AGUAAUUCAAGATCA;

2,518-A & 2,528-A:

5΄-GAAAAAUGUGAAGGACU[A]{.ul}UCGUAACGG[A]{.ul}AGUAAUUCAAGATCA;

2,518-U & 2,528-U:

5΄-GAAAAAUGUGAAGGACU[U]{.ul}UCGUAACGG[U]{.ul}AGUAAUUCAAGATCA;

2,518-A & 2,528-U:

5΄-GAAAAAUGUGAAGGACU[A]{.ul}UCGUAACGG[U]{.ul}AGUAAUUCAAGATCA.

RNA pull-down, gel shift and cross-linking {#SEC2-5}
------------------------------------------

The *in vitro* pull-down assays were performed as described ([@B7]). The eluted protein samples were separated on 4--12% polyacrylamide Bis-Tris gels (NP0321BOX, Invitrogen) and stained with SYPRO Ruby Protein Gel Stain (S12000, Thermo Scientific) according to the manufacturer\'s instructions. Proteins in gel slices or in the entire pulled-down protein sample were digested with trypsin and identified using LC--MS/MS by the Donald Danforth Plant Science Center (Washington University, St Louis, MO, USA).

For the gel shift in Figure [1B](#F1){ref-type="fig"}, the gel-purified 5΄ ^32^P-labeled RNA oligos were refolded by heating at 90°C for 1 min, then at 30°C for 5 min. A total of 3 μl nuclear extract and 6 μl refolded RNA were incubated together at room temperature for 30 min, and then at 4°C for 2 h. Each sample was mixed with 1 μl 50% glycerol, separated on an 8% polyacrylamide, 44.5 mM Tris--borate (pH 8.3 at 25 °C, pH 8.9 at 5 °C), and 1 mM Na~2~EDTA (ethylenediaminetetraacetic acid) native gel at 5 °C, and visualized by phosphorimaging using the Personal Molecular Imager (Bio-Rad).

For the gel shift and ultraviolet cross-linking assays in Figure [2C](#F2){ref-type="fig"} and [D](#F2){ref-type="fig"}, gel-purified 5΄ ^32^P-labeled RNA oligos were refolded by incubating at 90°C for 1 min, then at room temperature for 3 min. The refolded RNA was combined with purified recombinant N-RRM, C-RBD or C-RBD mutant protein either in 10 mM Tris-Cl (pH 7.4), 100 mM KCl, 2.5 mM MgCl~2~ (gel shift) or in 10 mM HEPES (pH 8.0), 50 mM KCl, 1 mM ethylenediaminetetraacetic acid (EDTA), 0.05% Triton X-100, 5% glycerol, 1 mM dithiothreitol (DTT), 10 μg/ml salmon sperm DNA (cross-linking) and the RNA--protein mixture was incubated for 30 min at 30°C, 600 rpm. For the gel shift assay in Figure [2C](#F2){ref-type="fig"}, each sample was mixed with 1 μl 50% glycerol, separated on an 8% polyacrylamide, 44.5 mM Tris--borate (pH 8.3 at 25 °C, pH 8.9 at 5 °C) and 1 mM Na~2~EDTA native gel at 5 °C, and visualized by phosphorimaging using the Personal Molecular Imager (Bio-Rad). Ultraviolet cross-linking was conducted at 254 nm, 150 mJ/cm^2^. The cross-linked protein samples were separated on 4--12% polyacrylamide Bis-Tris gels, visualized by phosphorimaging, and stained in PageBlue Protein Staining Solution (24620, Thermo Scientific).

RNA structural probing by RNase V1/S1 {#SEC2-6}
-------------------------------------

The synthetic RNA oligos were 5΄ end-labeled with γ-^32^P-ATP by T4 polynucleotide kinase (70031, Affymetrix), gel purified and re-folded. Structural probing assays with RNase T1, nuclease S1, and RNase V1 were performed as previously described ([@B6]).

Electron microscopy {#SEC2-7}
-------------------

The purified GST-fusion C-RBD or N-RRM domain of the HNRNPG protein was diluted to 5 μM in 10 mM Tris-Cl (pH 7.4), 100 mM KCl, 2.5 mM MgCl~2~. The 5 μl sample solution was spotted on a 400 mesh carbon grid, washed with 1--2 drops of water, stained with 2 drops of 1% uranyl acetate, blotted and dried in air. Images were obtained at 68.6K× magnification on an FEI Tecnai G2 F30 Super Twin scanning transmission electron microscope.

PAR-CLIP and PAR-CLIP--MeRIP {#SEC2-8}
----------------------------

Photoactivatable ribonucleoside-enhanced cross-linking and immunoprecipitation (PAR-CLIP) was performed as previously reported ([@B29]) with the following modifications. HEK293T cells in 15-cm plates treated following normal PAR-CLIP procedures were lysed and digested with a combination of RNase I (AM2295, Ambion, 12 μl diluted 1:50 with H~2~O) and Turbo DNases (2 μl) for 3 min at 37°C, shaking at 1100 rpm. The lysate was then immediately cleared by spinning at 14 000 rpm, 4°C for 30 min and placed on ice for further use. HNRNPG binding sites were identified by PARalyzer v1.1 with default settings ([@B30]).

The PAR-CLIP--methylated RNA immunoprecipitation (MeRIP) experiment applied m^6^A-antibody immunoprecipitation ([@B31]) to the HNRNPG PAR-CLIP RNA samples (from HEK293T cells in eight 15-cm plates). The HNRNPG PAR-CLIP RNA sample was incubated with m^6^A-specific antibody (202003, SYSY), RNase inhibitor (80 units, Sigma-Aldrich), human placental RNase inhibitor (NEB) in 200 μl 1× IP buffer (50 mM Tris-Cl (pH 7.4), 750 mM NaCl and 0.5% (vol/vol) Igepal CA-630) at 4°C for 2 h under gentle shaking conditions. For each PAR-CLIP--MeRIP experiment, 20 μl Protein A beads (10002D, Thermo Scientific) were washed twice with 1 ml 1× IP buffer, blocked by a 2-h incubation with 100 μl 1× IP buffer supplemented with BSA (0.5 mg/ml), RNasin and human placental RNase inhibitor, and then washed twice with 100 μl 1× IP buffer. The pre-blocked Protein A beads were then combined with the prepared immuno-reaction mixture and incubated at 4°C for 2 h, followed by three washes with 100 μl 1× IP buffer. Finally, the RNA was eluted by 1-h incubation with 20 μl elution buffer (1× IP buffer and 6.7 mM m^6^A, Sigma-Aldrich) under gentle shaking conditions, and then purified by ethanol precipitation. The purified RNA sample (IP) as well as the input PAR-CLIP RNA sample (input control) were used for library construction.

Libraries for both PAR-CLIP and PAR-CLIP--MeRIP experiments were prepared using the TruSeq Small RNA Sample Preparation Kit (RS-200-0012, Illumina) according to the manufacturer\'s instructions, and then sequenced by Illumina HiSeq 2000 with single-end 50-bp reads. The control and IP samples from PAR-CLIP--MeRIP experiments were sequenced together in two lanes of one flow cell, and the reads from two lanes of each sample were combined for analysis. (The control and knockdown (KD) samples from *METTL3/L14* KD experiments were sequenced and combined for analysis in the same manner.) The raw sequencing data was trimmed using the Trimmomatic computer program version 0.30 to remove adaptor sequences, and mapped to the human genome version hg19 by Bowtie 1.0.0 ([@B32]) without any gaps and allowing for at most two mismatches. Approximately 20 million reads were mapped to hg19 for each sample.

Detection and distribution analysis of m^6^A sites within HNRNPG binding sites {#SEC2-9}
------------------------------------------------------------------------------

Detection of HNRNPG-bound m^6^A sites by PAR-CLIP--MeRIP involves comparing the read counts of the IP sample with those of the control (Ctrl) sample as follows: (i) we identified all AGRAC motifs within HNRNPG PAR-CLIP peaks; (ii) we performed transcriptome-wide scanning to compare read counts of each AGRAC motif in ([@B1]) from both Control and IP samples to calculate the fold change score, score = log~2~ (Counts~IP~/Counts~Control~). AGRAC motifs with log~2~ (Counts~IP~/Counts~Control~) larger than 0.5 were considered to be HNRNPG-bound m^6^A sites.

Detection of HNRNPG-bound m^6^A sites by PAR-CLIP involves comparing the read counts of the *METTL3/L14* KD sample with that of the control (Ctrl) sample as follows: (i) we identified all AGRAC motifs within HNRNPG PAR-CLIP peaks; (ii) we performed transcriptome-wide scanning to compare read counts of each AGRAC motif in ([@B1]) from both Control and *METTL3/L14* KD samples to calculate the fold change score, score = log~2~ (Counts~KD~/Counts~Control~). AGRAC motifs with log~2~ (Counts~KD~/Counts~Control~) \<−0.5 were considered to be HNRNPG-bound m^6^A sites.

High-confidence m^6^A (HC m^6^A) sites within HNRNPG binding sites fulfill the following two requirements: (i) log~2~ (Counts~IP~/Counts~Control~) \> 0.5; (ii) log~2~ (Counts~KD~/Counts~Control~) \<−0.5. Pie charts illustrating the distribution of high-confidence HNRNPG-bound m^6^A sites within each segment were made using the following hierarchy: intron \> ncRNA \> 3΄UTR \> 5΄UTR \> CDS \> intergenic.

RNA-sequencing {#SEC2-10}
--------------

RNA-seq experiments were performed on two replicates of RNA samples from *HNRNPG* knockdown (KD1 and KD2) as well as control HEK293T cells 48 h after transfection. Total RNA was extracted using the RNeasy Plus kit (74104, Qiagen). Libraries were prepared using the TruSeq Stranded mRNA LT Sample Prep Kit (RS-122-9005DOC, Illumina). KD and control samples were sequenced together in four lanes in one flow cell. All samples were sequenced by Illumina HiSeq 2000 with paired-end 100-bp reads. The reads from the four lanes of each sample were combined for all analyses. The RNA-seq data were mapped using the splice-aware alignment algorithm TopHat version 1.1.4 ([@B33]) based on the following parameters: tophat --num-threads 8 --mate-inner-dist 200 --solexa-quals --min-isoform-fraction 0 --coverage-search-segment-mismatches 1. Gene expression level changes were analyzed using Cuffdiff ([@B34]). Approximately 140--200 million reads were mapped for each sample. Differential splicing was determined using DEXSeq ([@B35]) based on Cufflinks-predicted, non-overlapping exons.

Evolutionary conservation, graphics and statistical analysis {#SEC2-11}
------------------------------------------------------------

Phylogenetic conservation analysis was performed by comparing PhyloP scores at high-confidence m^6^A-containing AGRAC motifs to those at randomly selected AGRAC sequences. The PhyloP scores were accessed from the precompiled PhyloP scores ([@B36]) (<ftp://hgdownload.soe.ucsc.edu/goldenPath/hg19/phyloP46way/>) for primates and vertebrates. *P*-values were evaluated using the Mann--Whitney--Wilcoxon test. The random selection was done separately for primates and for vertebrates.

Sequence logos were generated using the WebLogo package. R statistical package was used for all statistical analysis (unless stated otherwise).

RT-PCR quantification {#SEC2-12}
---------------------

Total RNA was extracted from HEK293T cells and reverse transcribed using the SuperScript III First-Strand Synthesis System (18080-051, Life Technologies). In order to validate the splicing changes identified from our RNA-seq data, we performed RT-PCR measurements using Taq DNA Polymerase (Thermo Scientific) under the following conditions: 95°C for 3 min, 30 cycles of \[95°C for 30 s, 55°C for 30 s, 72°C for 1 min\], and then finally 72°C for 10 min. For the target alternatively spliced exon, we designed and used primers annealing to both neighboring constitutive exons. The PCR products were separated on a 10% polyacrylamide, 89 mM Tris--borate (pH 8.3 at 25 °C) and 2 mM Na~2~EDTA gel and stained with SYBR Gold Nucleic Acid Gel Stain (S11494, Thermo Scientific).

To validate the gene expression level changes identified from our RNA-seq data, we performed RT-qPCR measurements using Power SYBR Green PCR Master Mix (4367659, Thermo Scientific) under the following conditions: 50°C for 3 min, followed by 95°C for 10 min, 40 cycles of \[95°C for 15 s, 60°C for 1 min\], and then 40°C for 1 min, 95°C for 15 s, and finally 60°C for 30 s.

The primer sequences are listed below (*Gene name*: forward primer; reverse primer): *C20orf72*: ACAGCGGATGATTCTGGAAC; TTCCTGGGGTGAAAGTATGC; *NASP*: TGTGCATGTGGAAGAGGAAG; GAAGGTGTGCATGTGGAAGA; *CTNNB1*: GAAAATCCAGCGTGGACAAT; CAGGACTTGGGAGGTATCCA; *PKIA* (primers_1): CCTGGTTTCCCCAAAGAAGT; TGATTGGAAACCTTCTTGTCTTT; *PKIA* (primers_2): TGGTAGCAATGACTGATGTGG; ACTTGCAGAGGAAACCAGGA; *RHBDF2* (primers_1): AGAGCCAGAGACCCAAGACA; CCCAAGACTCAGAGAGGCA; *RHBDF2* (primers_2): GAGTACCCAGGAAGCTGCAC; TACAGATGCTCCGGTGTCAA; *SCD* (primers_1): TGTTCGTTGCCACTTTCTTG; GGGGGCTAATGTTCTTGTCA; *SCD* (primers_2): CTCCACTGCTGGACATGAGA; AATGAGTGAAGGGGCACAAC; *SFXN2* (primers_1): GCCAGACTGGTCTCGAACTC; ACGGTCCCCTTTTTAGCACT; *SFXN2* (primers_2): CCTGGGATTGGTCGAAAAG; AAATGCCACCAGTTACAGCC; *ANKRD52* (primers_1): CTGTGCCGAGACTTTAAGGG; GCGAGTATCCGCTGTAATCC; *ANKRD52* (primers_2): AGACGCTGGTGAATCTGGAC; GCTGTAAGCACCTCCACACA; *MBNL1* (primers_1): AATATCTTCATCCACCCCCA; TTGGCTAGTTGCATTTGCTG; *MBNL1* (primers_2): GCTGCATCTGTCTATGCCAA; CGAATTTCCAAGCTGCTTTC; *VPRBP* (primers_1): GCTGACAAAAGAGGCTGACC; GCTGAGGATGAGCAGTAGGG; *VPRBP* (primers_2): TGATAGAATATGGCCCAGCG; CCAATTGCAGGCAATAGAAA; *ZBTB4* (primers_1): TTCCATGCCTTTGGATCTTC; ATTTGGGGGTCAAGATAGGG; *ZBTB4* (primers_2): GCTCACTTCAGCCCCACTAC; AGACGAGGAAGAGGAGGAGG; *SSU72* (primers_1): GCACTTCCCGACATACCTGT; GCACAATGACAGCAGCATCT; *SSU72* (primers_2): AAATAAGAGAATCAAGCCCCG; TTCCACCACCTGGTCATACA; *SPOPL* (primers_1): GCTGGAGTCGTAACTCGGAA; CGCTCCTAAACTTCTTCCCC; *SPOPL* (primers_2): GGAGGTTTGTTCTGGTGCAT; GCCCTTAAGAAGCACACTGG; *EDEM1* (primers_1): AGCCTCCTTTCTGCTCACAG; GGTGTTTTCAAAAGCAGGGA; *EDEM1* (primers_2): ATGAGCATCTTCGGGAATTG; AACTCATGAGGTTTCGGCCT.

RESULTS {#SEC3}
=======

HNRNPG preferentially binds m^6^A-modified RNA {#SEC3-1}
----------------------------------------------

In order to identify nuclear m^6^A reader proteins, we conducted an RNA pull-down assay using methylated and unmethylated forms of a 34-nt hairpin from the lncRNA MALAT1 (Figure [1A](#F1){ref-type="fig"}). This hairpin contains a single m^6^A site corresponding to position 2,515 of MALAT1, which is 63% m^6^A-modified in HeLa cells ([@B6]). Following incubation with HeLa nuclear extract, the methylated and unmethylated forms of the MALAT1 hairpin pulled down different protein complexes, which were resolved on native gels (Figure [1B](#F1){ref-type="fig"}). Denaturing gel electrophoresis (Figure [1C](#F1){ref-type="fig"}) and mass spectrometry ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}) further revealed that the protein HNRNPG was enriched in the pull-down with the m^6^A-methylated hairpin. These results identify HNRNPG as an m^6^A reader protein that preferentially binds an m^6^A-modified hairpin from the lncRNA MALAT1.

HNRNPG is a ubiquitously expressed RNA binding protein encoded by the gene *RBMX* (RNA binding motif protein, X chromosome) ([@B37]). A dominant function of HNRNPG is the regulation of alternative splicing ([@B38],[@B39]), but HNRNPG also functions in other cellular processes including DNA repair ([@B40]), sister chromatid cohesion ([@B41]), and transcriptional regulation ([@B42]). Notably, HNRNPG has been shown to either positively or negatively regulate the inclusion of several disease-related exons ([@B38],[@B39]). In addition, HNRNPG plays an important role in neural development ([@B43]), and a frameshift mutation in the C-terminal region of HNRNPG causes an intellectual disability syndrome in humans ([@B44]).

HNRNPG binds the MALAT1 hairpin through a low-complexity region {#SEC3-2}
---------------------------------------------------------------

HNRNPG is composed of an N-terminal globular RNA recognition motif of ∼90 amino acids, followed by ∼300 amino acids of low-complexity sequence, in which two-thirds of the amino acid residues are serine, arginine, glycine, and proline (Figure [2A](#F2){ref-type="fig"}). In addition to the N-terminal RNA recognition motif (N-RRM), which binds A/C-rich sequences in single-stranded RNA ([@B37]), the C-terminal 58 amino acids of the low-complexity sequence have been shown to bind an RNA hairpin with an A/G-rich motif ([@B45]). This C-terminal RNA binding domain (C-RBD) is highly conserved across species ([@B45]), and a frameshift mutation in this region causes an intellectual disability syndrome in humans ([@B44]). However, the RNA sequence and structural preferences for the HNRNPG C-RBD have yet to be determined.

Due to the extensive low-complexity region of HNRNPG, the full-length recombinant protein was difficult to express and purify by us and others ([@B45]). Instead, we purified each of the two known RNA binding domains of HNRNPG, the N-RRM and the C-RBD, fused to an N-terminal glutathione S-transferase (GST). Similar to other low-complexity sequences ([@B25],[@B46]), the purified C-RBD self-assembled into higher-order structures, forming aggregates of ∼100 nm in size that were visible by electron microscopy (Figure [2B](#F2){ref-type="fig"}). We conducted gel shift assays to evaluate the binding of the N-RRM and C-RBD to the methylated and unmethylated MALAT1 hairpins. While the N-RRM did not shift the MALAT1 hairpin, the C-RBD shifted both hairpins with high cooperativity (Figure [2C](#F2){ref-type="fig"}). However, quantification was difficult to analyze due to the protein concentration dependent aggregation of the C-RBD. Therefore, we turned to ultraviolet cross-linking assays (Figure [2D](#F2){ref-type="fig"}). Similar to the gel shift assays, the N-RRM did not cross-link to the MALAT1 hairpin, whereas the C-RBD cross-linked to both hairpins and more strongly to the m^6^A-modified MALAT1 hairpin.

The C-RBD contains three Arg-Gly-Gly (RGG) repeats. Since RGG motifs frequently function in RNA binding ([@B47]), we evaluated the role of the RGG motif by introducing arginine-to-phenylalanine mutations in the three RGG repeats of the C-RBD (Figure [2D](#F2){ref-type="fig"}; [Supplementary Figures S1C and 2A](#sup1){ref-type="supplementary-material"}). Mutating one or two of the RGG motifs did not alter cross-linking efficiency. However, introducing mutations in all three RGG motifs abolished cross-linking to both the methylated and unmethylated MALAT1 hairpins, suggesting that the RGG repeats in the C-RBD mediate MALAT1 hairpin binding.

m^6^A alters RNA structure and increases the accessibility of an HNRNPG binding motif {#SEC3-3}
-------------------------------------------------------------------------------------

To examine transcriptome-wide binding sites of HNRNPG, we performed PAR-CLIP against HNRNPG in HEK293T cells. HNRNPG PAR-CLIP of biological replicates yielded a total of 354,057 HNRNPG binding sites. AGRAC (R = A/G) was the most enriched motif among HNRNPG-bound RNAs, accounting for ∼30% (106,300) of HNRNPG binding sites identified by PAR-CLIP (Figure [3A](#F3){ref-type="fig"}). The AGRAC motif overlaps with the m^6^A consensus motif RRACH, indicating that a large fraction of HNRNPG binding sites could be m^6^A-modified.

The preferential binding of HNRNPG to m^6^A-modified RNA can be mediated by direct recognition of m^6^A, or through an effect of m^6^A on the accessibility of its RNA binding motif. Mutating the m^6^A site in the MALAT1 hairpin to G, C, or U led to increased pull-down of HNRNPG from nuclear extract (Figure [3B](#F3){ref-type="fig"}). This result indicates that the preferential binding of HNRNPG to the methylated hairpin does not depend on the presence of the *N*^6^-methyl group of the m^6^A residue.

We then investigated whether m^6^A modification influences the secondary structure of the MALAT1 hairpin using structural mapping. We used S1 nuclease, which specifically cuts single-stranded regions and RNase V1, which specifically cuts double-stranded, stacked regions of RNA (Figure [3C](#F3){ref-type="fig"}). Upon m^6^A modification, the MALAT1 hairpin became more single-stranded in the region surrounding the m^6^A site as shown by both increased S1 cuts and decreased V1 cuts in the region around the m^6^A site. Our structural mapping results are consistent with m^6^A disrupting the hairpin structure and increasing the accessibility of its surrounding nucleotides. The affected region in the MALAT1 hairpin included the AGGAC sequence, which matches the AGRAC motif found in the dominant HNRNPG binding sites identified by PAR-CLIP (Figure [3A](#F3){ref-type="fig"}).

To evaluate the role of the AGGAC sequence for HNRNPG binding to the MALAT1 hairpin, we switched individual base pairs involving the AGG\[m^6^A\]C, in order to disrupt the sequence while minimizing the effect on hairpin structure. Each of these pairwise mutations in the MALAT1 hairpin led to decreased HNRNPG pull-down from nuclear extract, with pairwise mutations at the m^6^A position having the smallest effect ([Supplementary Figure S2B](#sup1){ref-type="supplementary-material"}). This result suggests that the AGG\[m^6^A\]C sequence is important for HNRNPG binding, with the exception of the m^6^A within this motif, which influences protein binding mainly by disrupting RNA structure to expose the surrounding bases. In addition, mutations that disrupted the structure of the MALAT1 hairpin led to increased cross-linking of the purified C-RBD protein, while double mutations that restored the hairpin structure reduced cross-linking back to the wild-type hairpin level ([Supplementary Figure S2C](#sup1){ref-type="supplementary-material"}). These results, together with the structural mapping data, indicate that m^6^A modification of the MALAT1 hairpin promotes HNRNPG binding by increasing the accessibility of the AGGAC motif (Figure [3D](#F3){ref-type="fig"}).

Transcriptome-wide identification of m^6^A sites facilitating HNRNPG interactions {#SEC3-4}
---------------------------------------------------------------------------------

To identify m^6^A-modified HNRNPG binding sites, we conducted HNRNPG PAR-CLIP followed by MeRIP of biological replicates ([@B20]). In this HNRNPG PAR-CLIP--MeRIP experiment, HNRNPG-bound RNAs were isolated by PAR-CLIP ('input' sample) and then used as the input for MeRIP to enrich the m^6^A-containing HNRNPG-bound RNAs ('IP' sample). HNRNPG PAR-CLIP--MeRIP yielded a total of 16,200 m^6^A-modified HNRNPG binding sites (log~2~ (IP/input) \> 0.5), including the m^6^A at position 2,515 of MALAT1 (Figure [4A](#F4){ref-type="fig"}). In addition, we conducted HNRNPG PAR-CLIP in cells depleted of either of the core m^6^A methyltransferase components METTL3 and METTL14 ([Supplementary Figure S3A](#sup1){ref-type="supplementary-material"}). Sites with decreased HNRNPG occupancy upon *METTL3* or *METTL14* knockdown were considered as m^6^A methyltransferase-dependent HNRNPG binding sites. We identified 67,229 AGRAC motifs that were located within HNRNPG PAR-CLIP peaks but showed decreased HNRNPG binding following either *METTL3* or *METTL14* knockdown. Among these sites, 37,750 showed decreased HNRNPG binding in both *METTL3* and *METTL14* knockdown cells ([Supplementary Figure S3B](#sup1){ref-type="supplementary-material"}). A total of 13,191 m^6^A methyltransferase-dependent AGRAC sites were also identified as m^6^A-modified HNRNPG binding sites by PAR-CLIP--MeRIP (Figure [4B](#F4){ref-type="fig"} and [C](#F4){ref-type="fig"}; [Supplementary Table S1](#sup1){ref-type="supplementary-material"}). In addition, these AGRAC sites were highly conserved across species ([Supplementary Figure S3C](#sup1){ref-type="supplementary-material"}). We designate these 13,191 sites as high-confidence HNRNPG-bound m^6^A sites.

![HNRNPG binds m^6^A-modified RNAs transcriptome-wide. (**A**) PAR-CLIP--MeRIP input and IP (m^6^A-IP) read counts in a region of the *MALAT1* transcript. The red arrowhead indicates the m^6^A site at position 2,515. (**B**) Identification of high-confidence HNRNPG-bound m^6^A sites (purple) as the overlap between m^6^A-modified HNRNPG binding sites, identified by HNRNPG PAR-CLIP--MeRIP (pink) and m^6^A methyltransferase-dependent HNRNPG-bound AGRAC sites, identified by HNRNPG PAR-CLIP in m^6^A methyltransferase (*METTL3* and *METTL14*) knockdown HEK293T cells (blue). (**C**) Regional distribution of high-confidence HNRNPG-bound m^6^A sites. (**D**) Comparison of the structure of AGRAC sequences at high-confidence HNRNPG-bound m^6^A sites (red) versus random AGRAC sequences (black) in human polyadenylated RNAs, based on parallel analysis of RNA structure (PARS) data ([@B48]). The *x*-axis denotes nucleotide position; the *y*-axis shows the PARS score. Positive PARS scores indicate double-stranded conformation; negative scores indicate single-stranded conformation. *P*--value, Mann--Whitney U test.](gkx141fig4){#F4}

Notably, using transcriptome-wide data from parallel analysis of RNA structure of human polyadenylated RNAs ([@B48]), we found that AGRAC sequences at high-confidence HNRNPG-bound m^6^A sites were less structured than random AGRAC sequences (Figure [4D](#F4){ref-type="fig"}), suggesting that the m^6^A-dependent structural change in the MALAT1 hairpin could be generalized to HNRNPG-bound AGRAC motifs transcriptome-wide.

m^6^A-dependent HNRNPG binding regulates gene expression and alternative splicing {#SEC3-5}
---------------------------------------------------------------------------------

HNRNPG regulates the transcription and alternative splicing of multiple genes ([@B38],[@B39],[@B42]). To examine the effect of HNRNPG on gene expression and splicing transcriptome-wide, we conducted mRNA sequencing in HEK293T cells depleted of HNRNPG with two different siRNAs (Figure [5A](#F5){ref-type="fig"}). If HNRNPG binding to m^6^A-modified RNAs contributes to its function as a regulator of transcription and splicing, then perturbations to cellular m^6^A modifications should affect the expression and splicing of HNRNPG-regulated genes. To test this prediction, we compared our *HNRNPG* knockdown mRNA-seq data to our previous mRNA-seq data from cells with a global reduction in m^6^A due to knockdown of *METTL3* or *METTL14* ([@B20]). Using Cuffdiff2 ([@B34]), we found that hundreds of m^6^A-containing RNA transcripts were similarly up- or downregulated by both *HNRNPG* knockdown and m^6^A methyltransferase knockdown (Figure [5B](#F5){ref-type="fig"}--[D](#F5){ref-type="fig"}). These results were validated by RT-qPCR ([Supplementary Figure S4A](#sup1){ref-type="supplementary-material"}). As a control, gene expression changes in cells depleted of the mRNA binding protein HNRNPU did not correlate with gene expression changes upon *METTL3* or *METTL14* knockdown (Figure [5B](#F5){ref-type="fig"}) ([@B49]), consistent with the observation that HNRNPU did not preferentially bind m^6^A-modified RNA in nuclear pull-down assays ([Supplementary Figure S1A](#sup1){ref-type="supplementary-material"}).

![m^6^A-dependent HNRNPG binding regulates mRNA abundance. (**A**) Western blot showing depletion of HNRNPG with two different siRNAs (KD1 and KD2) for mRNA-seq experiments. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a loading control. (**B**) Number of genes with correlated changes in expression upon *HNRNPG* knockdown and m^6^A methyltransferase (*METTL3* or *METTL14*) knockdown. HCG-m^6^A, high-confidence HNRNPG-bound m^6^A site. mRNA-seq data from *HNRNPU* knockdown HEK293T cells (Gene Expression Omnibus, GSE34995 ([@B49])) were analyzed as a control. (**C** and **D**) mRNA-seq reads for *SPOPL* (speckle-type POZ protein-like) transcripts in control, *HNRNPG* knockdown (C) and m^6^A methyltransferase knockdown (D) cells. The arrowhead indicates the m^6^A site.](gkx141fig5){#F5}

Next, we used DEXSeq ([@B35]) to examine changes in alternative splicing. Splicing changes resulting from *HNRNPG* knockdown were correlated with splicing changes resulting from m^6^A methyltransferase knockdown (Figure [6A](#F6){ref-type="fig"} and [Supplementary Figure S5A--B](#sup1){ref-type="supplementary-material"}). In particular, ∼1,000 exons in genes with high-confidence HNRNPG-bound m^6^A sites were similarly up- or downregulated by *HNRNPG* knockdown and m^6^A methyltransferase knockdown (Figure [6B](#F6){ref-type="fig"}). For example, both HNRNPG knockdown and m^6^A methyltransferase knockdown reduced the inclusion of an exon in the *NASP* transcript, which encodes nuclear autoantigenic sperm protein (Figure [6C](#F6){ref-type="fig"} and [D](#F6){ref-type="fig"}). HNRNPG PAR-CLIP--MeRIP revealed an m^6^A-modified HNRNPG binding site in a nearby intron, suggesting that HNRNPG binding to this m^6^A-modified site might promote inclusion of the alternatively spliced exon. The HNRNPG- and m^6^A methyltransferase-dependent regulation of exon inclusion in *NASP* and two other transcripts was validated by RT-PCR (Figure [6E](#F6){ref-type="fig"}; [Supplementary Figure S5C and D](#sup1){ref-type="supplementary-material"}). These results suggest that HNRNPG binding to m^6^A-modified transcripts can regulate the alternative splicing of nearby exons.

![m^6^A-dependent HNRNPG binding regulates alternative splicing. (**A**) Splicing changes of annotated differentially expressed exons upon *HNRNPG* knockdown with siRNA KD2 (*x*-axis) and m^6^A methyltransferase (*METTL3* or *METTL14*) knockdown (*y*-axis), by log ratio of normalized counts relative to control knockdown, log~2~ (KD/Control). Pearson\'s correlation coefficient r and *P*-values are shown for each panel. (**B**) Number of exons for which changes in exon usage are correlated upon *HNRNPG, HNRNPC*, and/or m^6^A methyltransferase (*METTL3* or *METTL14*) knockdown. For *HNRNPG* knockdown, only exons in genes with high-confidence HNRNPG-bound m^6^A sites were counted. For *HNRNPC* knockdown, only exons in genes with high-confidence m^6^A-switches were counted ([@B20]). (**C** and **D**) mRNA-seq reads for *NASP* transcripts in control, *HNRNPG* knockdown (C) and m^6^A methyltransferase knockdown (D) cells. The yellow arrowhead indicates the alternatively spliced exon; the red arrowhead indicates the m^6^A site. (**E**) Reverse transcription and PCR (RT-PCR) validating differential exon usage in *NASP*. Data shown as mean; error bar = standard deviation; *n* = 3 biological replicates.](gkx141fig6){#F6}

The m^6^A reader protein HNRNPC also binds m^6^A-modified RNAs through an m^6^A-switch mechanism. Previous results revealed thousands of RNA transcripts and hundreds of exons that are similarly up- or downregulated by *HNRNPC* knockdown and m^6^A methyltransferase knockdown ([@B20]). However, \<10% of these transcripts and none of these exons were also co-regulated by *HNRNPG* and m^6^A methyltransferase knockdown ([Supplementary Figure S4B](#sup1){ref-type="supplementary-material"} and Figure [6B](#F6){ref-type="fig"}). Thus, while HNRNPC and HNRNPG both regulate gene expression and alternative splicing by binding to m^6^A-modified transcripts, the target genes regulated by m^6^A-dependent binding of HNRNPC are largely distinct from those regulated by m^6^A-dependent binding of HNRNPG. These results suggest that m^6^A-promoted HNRNPG and HNRNPC binding influence different subsets of gene transcripts.

DISCUSSION {#SEC4}
==========

In this study, we identified HNRNPG as a new m^6^A 'reader' protein that uses a low-complexity region to bind m^6^A-modified RNAs. Rather than directly recognizing the *N*^6^-methyl group, HNRNPG binds a purine-rich motif that becomes accessible upon m^6^A modification of an RNA hairpin. We identified 13,191 high-confidence HNRNPG-bound m^6^A sites transcriptome-wide and showed that HNRNPG and m^6^A modification cooperate to regulate gene expression and alternative splicing. These results demonstrate a role for the low-complexity domain of HNRNPG in the binding of m^6^A-modified RNAs, and suggest that the m^6^A-dependent binding of HNRNPG functions in the regulation of gene expression.

In the m^6^A-switch mechanism, m^6^A modulates protein binding by inducing an RNA structural change that alters the accessibility of a protein binding site. In the case of the m^6^A reader HNRNPC, m^6^A modification disrupts base-pairing and exposes a U-rich binding site for HNRNPC in the opposite strand ([@B20],[@B50]). HNRNPG binding to m^6^A-modified RNA also depends on an m^6^A-induced structural change. However, in contrast to HNRNPC, HNRNPG binds to a purine-rich motif that includes the m^6^A site. Since the HNRNPG binding motif overlaps with the m^6^A site, HNRNPG binding could compete with the binding of direct m^6^A readers such as the YTH domain proteins. HNRNPG might also modulate the binding of other m^6^A readers that use RNA structural changes as a readout for m^6^A. Although we found no indication that HNRNPG and HNRNPC cooperate to regulate the alternative splicing of m^6^A-containing transcripts, positive or negative cooperativity between these and other m^6^A readers may play a role in the regulation of other cellular processes.

Unlike previously described m^6^A reader proteins, which all bind m^6^A-modified RNA through folded domains, HNRNPG binds to m^6^A-modified RNA through a low-complexity region that self-assembles into large particles *in vitro* (Figure [2B](#F2){ref-type="fig"}). Interactome studies have revealed that many RNA binding proteins lack canonical RNA binding domains, and suggest that intrinsically disordered and low-complexity regions play an important role in RNA binding ([@B24]). In fact, low-complexity sequences are prevalent in RNA binding proteins, and an estimated one-third of RNA binding proteins are highly disordered ([@B23]). Unstructured RGG repeats are particularly common in RNA binding proteins and have been shown to mediate structure- and sequence-specific RNA binding ([@B47]). In addition to their widespread role in RNA binding, low-complexity domains frequently function in protein--protein interactions ([@B24]), are necessary and sufficient for the formation of granule-like structures *in vitro* ([@B25]), and are common sites of disease mutations that disrupt the balance between the assembly and clearance of ribonucleoprotein granules in the cell ([@B24],[@B26]). Several other m^6^A reader proteins contain low-complexity regions, but these regions have not been shown to directly bind m^6^A-modified RNAs. The low-complexity regions of the YTH proteins function in their recruitment to various cellular bodies ([@B12],[@B13],[@B15]). The RNA recognition motifs of the m^6^A reader HNRNPA2B1 show only a slight preference for m^6^A-modified RNAs *in vitro* ([@B22]), and it is yet to be determined whether this protein directly binds to m^6^A. HNRNPA2B1 also has a glycine-rich low-complexity domain with four RGG motifs, which might contribute to the preferential binding of HNRNPA2B1 to m^6^A-modified RNA. Moreover, HNRNPA2B1 may also use an m^6^A-switch mechanism to selectively bind m^6^A-modified RNAs. Thus, it is possible that HNRNPA2B1 and HNRNPG both use low-complexity regions and an m^6^A-switch mechanism to bind m^6^A-modified transcripts.

Our results reveal that HNRNPG regulates the alternative splicing of ∼1,000 exons in m^6^A-modified transcripts, but the mechanism for m^6^A-dependent splicing regulation by HNRNPG remains unclear. HNRNPG might recruit or compete with splicing factors for binding to m^6^A-modified transcripts, similar to the m^6^A reader YTHDC1 ([@B15]). In addition, both the N-terminal RRM and other parts of the low-complexity region of HNRNPG could contribute to the m^6^A-dependent regulation of splicing. RNA binding proteins frequently contain multiple repeats or combinations of RNA binding domains. This modular domain structure can contribute to RNA binding affinity or specificity, define the spacing between binding sites, organize RNA topology, or allow a single protein to simultaneously interact with multiple RNA molecules ([@B51]). Given that the regulation of alternative splicing by RNA binding proteins is highly position-dependent ([@B52]), the role of HNRNPG in splicing regulation is likely to be strongly dependent on the relationship between its different RNA binding domains.

The reversibility of m^6^A modifications allows cells to dynamically regulate modification levels and fine-tune the fate of RNA transcripts. Indeed, modification fractions vary widely among different m^6^A sites ([@B6]) and are regulated in response to external stimuli ([@B7],[@B8]). The heterogeneity and dynamic nature of m^6^A modification make it a useful mechanism for control of RNA fate. In addition to its role in binding m^6^A-modified RNA, the low-complexity region of HNRNPG likely functions in granule formation. Cellular granules play an important role in regulating the localization of both RNA transcripts and RNA binding proteins ([@B26]), which can in turn influence RNA splicing, translation and turnover, all of which are processes regulated by m^6^A ([@B9]--[@B17]). The relationship between HNRNPG granule formation and binding to m^6^A-modified RNAs could be a key to its function in the m^6^A-dependent regulation of gene expression and alternative splicing.

Many cellular functions of m^6^A are mediated by m^6^A reader proteins. HNRNPG is the second m^6^A reader protein shown to use the m^6^A-switch mechanism ([@B20]), strongly suggesting that m^6^A-mediated changes in RNA structure might impact interactions with many other RNA binding proteins. At the same time, HNRNPG differs from previously discovered m^6^A reader proteins in that it uses a low-complexity region to bind to m^6^A-modified RNA. Moreover, HNRNPG influences a large number of alternative splicing events in an m^6^A-dependent manner. In the future, it will be important to investigate the mechanisms by which interactions between the low-complexity region of HNRNPG and m^6^A-modified RNA modulate alternative splicing in the cell.
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